Article

10P Neoadjuvant chemotherapy with bevacizumab for IIb stage cervical cancer: Is it time to rethink standard of care?

F.M. Djuraev1Oncology Branch, Urologic Complex Clinic, Tashkent, UzbekistanA.S. Abdujapparov2Radiation Oncology, Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan

ESMO Openjournal2023en

ABI

Abstract

Background: Detection of residual tumor after radio-chemotherapy (RCX) in patients with locally advanced cervical cancer creates problems in clinical management.The aim of study is to evaluate the survival effect and prognostic importance of the residual tumor limited to the uterus in patients with advanced cervical cancer who received primary RCX.

Topics

Endometrial and Cervical Cancer Treatments Cervical Cancer and HPV Research Gastric Cancer Management and Outcomes

Identifiers

DOI: 10.1016/j.esmoop.2023.100865

Citations and references

Cited by 00 references

Metrics — AkademScholar · Coming soon